Sangamo Therapeutics, Inc. (SGMO)
USD 0.63
(-10.88%)
USD 0.63
(-10.88%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -257.83 Million USD | -34.09% |
| 2022 | -192.27 Million USD | -7.84% |
| 2021 | -178.29 Million USD | -47.2% |
| 2020 | -121.12 Million USD | -59.75% |
| 2019 | -75.81 Million USD | -10.95% |
| 2018 | -68.33 Million USD | -25.23% |
| 2017 | -54.56 Million USD | 23.85% |
| 2016 | -71.65 Million USD | -76.05% |
| 2015 | -40.7 Million USD | -54.08% |
| 2014 | -26.41 Million USD | 0.78% |
| 2013 | -26.62 Million USD | -19.58% |
| 2012 | -22.26 Million USD | 37.72% |
| 2011 | -35.75 Million USD | -43.84% |
| 2010 | -24.85 Million USD | -33.72% |
| 2009 | -18.58 Million USD | 23.52% |
| 2008 | -24.3 Million USD | -13.14% |
| 2007 | -21.48 Million USD | -20.24% |
| 2006 | -17.86 Million USD | -34.39% |
| 2005 | -13.29 Million USD | 3.8% |
| 2004 | -13.81 Million USD | -32.45% |
| 2003 | -10.43 Million USD | 64.95% |
| 2002 | -29.76 Million USD | -17.88% |
| 2001 | -25.24 Million USD | -178.5% |
| 2000 | -9.06 Million USD | -138.58% |
| 1999 | -3.8 Million USD | -15.68% |
| 1998 | -3.28 Million USD | -134.64% |
| 1997 | -1.4 Million USD | -354.55% |
| 1996 | -308 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -36.12 Million USD | 26.4% |
| 2024 Q1 | -49.08 Million USD | 18.59% |
| 2023 Q4 | -60.29 Million USD | 42.11% |
| 2023 Q1 | 21.13 Million USD | 140.66% |
| 2023 Q3 | -104.16 Million USD | 9.03% |
| 2023 Q2 | -114.5 Million USD | -641.84% |
| 2023 FY | -257.83 Million USD | -34.09% |
| 2022 Q4 | -51.97 Million USD | 2.22% |
| 2022 Q3 | -53.15 Million USD | -23.12% |
| 2022 FY | -192.27 Million USD | -7.84% |
| 2022 Q1 | -43.97 Million USD | -17.28% |
| 2022 Q2 | -43.17 Million USD | 1.83% |
| 2021 Q2 | -47.16 Million USD | -2.69% |
| 2021 Q1 | -45.93 Million USD | -13.12% |
| 2021 FY | -178.29 Million USD | -47.2% |
| 2021 Q3 | -47.68 Million USD | -1.1% |
| 2021 Q4 | -37.49 Million USD | 21.37% |
| 2020 Q3 | -1.55 Million USD | 95.69% |
| 2020 Q1 | -42.91 Million USD | -1042.11% |
| 2020 Q2 | -35.92 Million USD | 16.27% |
| 2020 Q4 | -40.6 Million USD | -2519.61% |
| 2020 FY | -121.12 Million USD | -59.75% |
| 2019 Q4 | 4.55 Million USD | 116.68% |
| 2019 Q2 | -30.28 Million USD | 28.15% |
| 2019 Q1 | -42.15 Million USD | -125.84% |
| 2019 FY | -75.81 Million USD | -10.95% |
| 2019 Q3 | -27.3 Million USD | 9.83% |
| 2018 Q4 | -18.66 Million USD | -45.32% |
| 2018 FY | -68.33 Million USD | -25.23% |
| 2018 Q1 | -20.18 Million USD | -54.21% |
| 2018 Q2 | -16.64 Million USD | 17.57% |
| 2018 Q3 | -12.84 Million USD | 22.82% |
| 2017 FY | -54.56 Million USD | 23.85% |
| 2017 Q3 | -12.35 Million USD | 1.1% |
| 2017 Q1 | -16.63 Million USD | -72.82% |
| 2017 Q2 | -12.49 Million USD | 24.9% |
| 2017 Q4 | -13.09 Million USD | -5.97% |
| 2016 FY | -71.65 Million USD | -76.05% |
| 2016 Q1 | -16.49 Million USD | -17.7% |
| 2016 Q2 | -26.57 Million USD | -61.12% |
| 2016 Q3 | -18.96 Million USD | 28.64% |
| 2016 Q4 | -9.62 Million USD | 49.25% |
| 2015 Q1 | -5.31 Million USD | -23.15% |
| 2015 Q2 | -12.12 Million USD | -127.98% |
| 2015 Q3 | -9.24 Million USD | 23.76% |
| 2015 Q4 | -14.01 Million USD | -51.57% |
| 2015 FY | -40.7 Million USD | -54.08% |
| 2014 Q1 | -7.57 Million USD | 7.02% |
| 2014 Q4 | -4.31 Million USD | 42.76% |
| 2014 Q3 | -7.54 Million USD | -8.08% |
| 2014 FY | -26.41 Million USD | 0.78% |
| 2014 Q2 | -6.98 Million USD | 7.81% |
| 2013 Q2 | -5.45 Million USD | 20.84% |
| 2013 Q1 | -6.88 Million USD | -97.96% |
| 2013 FY | -26.62 Million USD | -19.58% |
| 2013 Q4 | -8.14 Million USD | -32.53% |
| 2013 Q3 | -6.14 Million USD | -12.75% |
| 2012 Q3 | -5.79 Million USD | -1.08% |
| 2012 Q1 | -7.26 Million USD | -14.29% |
| 2012 FY | -22.26 Million USD | 37.72% |
| 2012 Q4 | -3.47 Million USD | 39.93% |
| 2012 Q2 | -5.72 Million USD | 21.19% |
| 2011 Q2 | -10.25 Million USD | -7.11% |
| 2011 FY | -35.75 Million USD | -43.84% |
| 2011 Q4 | -6.35 Million USD | 33.44% |
| 2011 Q1 | -9.57 Million USD | -15.11% |
| 2011 Q3 | -9.55 Million USD | 6.87% |
| 2010 FY | -24.85 Million USD | -33.72% |
| 2010 Q1 | -3.97 Million USD | -66.23% |
| 2010 Q2 | -3.86 Million USD | 2.97% |
| 2010 Q3 | -8.69 Million USD | -125.26% |
| 2010 Q4 | -8.32 Million USD | 4.3% |
| 2009 FY | -18.58 Million USD | 23.52% |
| 2009 Q2 | -4.51 Million USD | 33.97% |
| 2009 Q1 | -6.83 Million USD | -165.42% |
| 2009 Q4 | -2.39 Million USD | 50.67% |
| 2009 Q3 | -4.85 Million USD | -7.54% |
| 2008 Q2 | -7.41 Million USD | 6.94% |
| 2008 Q1 | -7.97 Million USD | -19.48% |
| 2008 Q4 | -2.57 Million USD | 59.4% |
| 2008 Q3 | -6.34 Million USD | 14.54% |
| 2008 FY | -24.3 Million USD | -13.14% |
| 2007 Q2 | -5.18 Million USD | 3.32% |
| 2007 FY | -21.48 Million USD | -20.24% |
| 2007 Q1 | -5.35 Million USD | 40.11% |
| 2007 Q4 | -6.67 Million USD | -56.33% |
| 2007 Q3 | -4.26 Million USD | 17.62% |
| 2006 FY | -17.86 Million USD | -34.39% |
| 2006 Q3 | -2.84 Million USD | 14.49% |
| 2006 Q2 | -3.32 Million USD | -21.25% |
| 2006 Q1 | -2.74 Million USD | -1.89% |
| 2006 Q4 | -8.94 Million USD | -214.52% |
| 2005 FY | -13.29 Million USD | 3.8% |
| 2005 Q2 | -3.38 Million USD | 4.87% |
| 2005 Q3 | -3.66 Million USD | -8.49% |
| 2005 Q4 | -2.69 Million USD | 26.56% |
| 2005 Q1 | -3.55 Million USD | -16.76% |
| 2004 FY | -13.81 Million USD | -32.45% |
| 2004 Q2 | -3.26 Million USD | -10.88% |
| 2004 Q1 | -2.94 Million USD | -75.12% |
| 2004 Q4 | -3.04 Million USD | 33.43% |
| 2004 Q3 | -4.57 Million USD | -40.13% |
| 2003 Q4 | -1.68 Million USD | 34.98% |
| 2003 Q2 | -3.27 Million USD | -13.09% |
| 2003 Q1 | -2.89 Million USD | -310.06% |
| 2003 FY | -10.43 Million USD | 64.95% |
| 2003 Q3 | -2.58 Million USD | 21.08% |
| 2002 Q3 | -20.94 Million USD | -476.7% |
| 2002 Q4 | -706 Thousand USD | 96.63% |
| 2002 Q1 | -4.48 Million USD | -33.3% |
| 2002 Q2 | -3.63 Million USD | 19.08% |
| 2002 FY | -29.76 Million USD | -17.88% |
| 2001 Q3 | -17.4 Million USD | -621.09% |
| 2001 Q1 | -2.06 Million USD | 26.49% |
| 2001 Q4 | -3.36 Million USD | 80.66% |
| 2001 FY | -25.24 Million USD | -178.5% |
| 2001 Q2 | -2.41 Million USD | -17.07% |
| 2000 Q2 | -1.72 Million USD | 36.53% |
| 2000 FY | -9.06 Million USD | -138.58% |
| 2000 Q3 | -1.81 Million USD | -5.39% |
| 2000 Q4 | -2.8 Million USD | -54.29% |
| 2000 Q1 | -2.71 Million USD | 0.0% |
| 1999 FY | -3.8 Million USD | -15.68% |
| 1998 FY | -3.28 Million USD | -134.64% |
| 1997 FY | -1.4 Million USD | -354.55% |
| 1996 FY | -308 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 41.434% |
| AlloVir, Inc. | -190.41 Million USD | -35.403% |
| Aptorum Group Limited | -2.82 Million USD | -9027.902% |
| Ardelyx, Inc. | -66.06 Million USD | -290.257% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -25.603% |
| Bicycle Therapeutics plc | -180.66 Million USD | -42.713% |
| AbCellera Biologics Inc. | -146.39 Million USD | -76.116% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -43.997% |
| Chimerix, Inc. | -82.09 Million USD | -214.064% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -478.053% |
| Elevation Oncology, Inc. | -45.7 Million USD | -464.132% |
| Alkermes plc | 355.75 Million USD | 172.474% |
| Fortress Biotech, Inc. | -60.63 Million USD | -325.204% |
| Fortress Biotech, Inc. | -60.63 Million USD | -325.204% |
| Agenus Inc. | -245.76 Million USD | -4.911% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -216.047% |
| Dyadic International, Inc. | -6.79 Million USD | -3694.165% |
| ImmuCell Corporation | -5.77 Million USD | -4364.917% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -27446.047% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -128.248% |
| Lantern Pharma Inc. | -15.96 Million USD | -1515.327% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1571.4% |
| Incyte Corporation | 597.59 Million USD | 143.144% |
| IO Biotech, Inc. | -86.08 Million USD | -199.514% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -342.302% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1254.946% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -337.13% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -56.666% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -68.526% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2932.949% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -373.762% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 594.365% |
| ContextLogic Inc. | -317 Million USD | 18.665% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -251.522% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 30.993% |
| MiMedx Group, Inc. | 67.43 Million USD | 482.317% |
| MEI Pharma, Inc. | 17.77 Million USD | 1550.281% |
| Novavax, Inc. | -545.06 Million USD | 52.697% |
| NextCure, Inc. | -62.72 Million USD | -311.063% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2481.925% |
| Onconetix, Inc. | -37.4 Million USD | -589.209% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -553.084% |
| Opthea Limited | -220.24 Million USD | -17.067% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -403.979% |
| Vaxcyte, Inc. | -402.26 Million USD | 35.905% |
| PDS Biotechnology Corporation | -42.94 Million USD | -500.414% |
| Precigen, Inc. | -95.9 Million USD | -168.843% |
| Pharming Group N.V. | -10.54 Million USD | -2344.359% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -27.897% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -950.528% |
| PureTech Health plc | -65.69 Million USD | -292.455% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -249.412% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -927.584% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -21.492% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1290.217% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -959.32% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -959.32% |
| Seer, Inc. | -86.27 Million USD | -198.841% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -846.586% |
| Acelyrin, Inc. | -381.64 Million USD | 32.441% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2055527.621% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -590.495% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -656.08% |
| Senti Biosciences, Inc. | -92.91 Million USD | -177.479% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -693.692% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -146.259% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -633.725% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1872.412% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -3756.859% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -778.111% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -806.196% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1170.667% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -348.3% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -314.153% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -94.6% |
| ChromaDex Corporation | -4.93 Million USD | -5121.365% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 54.991% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -7085.925% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -404.977% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -152.602% |
| CRISPR Therapeutics AG | -153.61 Million USD | -67.848% |
| Precision BioSciences, Inc. | -61.31 Million USD | -320.475% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -60.215% |
| Innoviva, Inc. | 179.72 Million USD | 243.461% |
| Jaguar Health, Inc. | -41.3 Million USD | -524.288% |
| Summit Therapeutics Inc. | -614.92 Million USD | 58.071% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -284.851% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -292.049% |
| ESSA Pharma Inc. | -26.58 Million USD | -869.933% |
| GlycoMimetics, Inc. | -36.89 Million USD | -598.74% |
| GT Biopharma, Inc. | -7.59 Million USD | -3293.853% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -6.824% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -396.545% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 461.057% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -424.9% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2491.853% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -4.982% |
| Aptose Biosciences Inc. | -51.2 Million USD | -403.507% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -162.295% |
| Soligenix, Inc. | -6.14 Million USD | -4098.703% |
| Century Therapeutics, Inc. | -136.67 Million USD | -88.648% |
| Kura Oncology, Inc. | -152.63 Million USD | -68.924% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -188.99% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2346.679% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 45695.876% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -45213.005% |
| Autolus Therapeutics plc | -208.38 Million USD | -23.729% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -258.607% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -264.194% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1089.916% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -14.464% |
| GRI Bio, Inc. | -13.03 Million USD | -1877.687% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -6135.969% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -107.787% |
| IGM Biosciences, Inc. | -246.41 Million USD | -4.632% |
| INmune Bio, Inc. | -30 Million USD | -759.208% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -133.207% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -511.064% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1515.315% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1532.36% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -331.986% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -154.857% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 6.626% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -8.382% |
| Verastem, Inc. | -87.36 Million USD | -195.113% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -375.808% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -59.81% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -121.014% |
| Histogen Inc. | -10.62 Million USD | -2327.559% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1704.685% |
| Surrozen, Inc. | -43.04 Million USD | -499.022% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1657.419% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4968.4% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -392.618% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -920.587% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -857.127% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2985.178% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -70.653% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -426.981% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -767.388% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2374.931% |
| Apollomics, Inc. | -172.6 Million USD | -49.38% |
| Amarin Corporation plc | -59.11 Million USD | -336.174% |
| Mesoblast Limited | -87.95 Million USD | -193.136% |
| Turnstone Biologics Corp. | -55.2 Million USD | -367.085% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -75.441% |
| Synaptogenix, Inc. | -6.03 Million USD | -4169.783% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1490.764% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -230.468% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5281.046% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2968.614% |
| Exelixis, Inc. | 207.76 Million USD | 224.097% |
| Better Therapeutics, Inc. | -39.76 Million USD | -548.468% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -79.114% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 51.226% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2018.225% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -3207.777% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -738.502% |
| Gritstone bio, Inc. | -138.49 Million USD | -86.173% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -299.955% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -6345.856% |
| Avid Bioservices, Inc. | -140.75 Million USD | -83.18% |
| Insmed Incorporated | -749.56 Million USD | 65.603% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1597.428% |
| MediWound Ltd. | -6.71 Million USD | -3739.056% |
| OmniAb, Inc. | -50.61 Million USD | -409.356% |
| Alector, Inc. | -130.39 Million USD | -97.737% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -126.716% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -397.292% |
| Zai Lab Limited | -334.62 Million USD | 22.948% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 20.419% |
| Aura Biosciences, Inc. | -76.4 Million USD | -237.44% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -9.887% |
| Immunic, Inc. | -93.61 Million USD | -175.425% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -89.731% |
| Veracyte, Inc. | -74.4 Million USD | -246.528% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -3259.121% |
| FibroGen, Inc. | -284.23 Million USD | 9.289% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -882.887% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3582.306% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1269.061% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 162.153% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1043.121% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 623.292% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2134.651% |
| Galecto, Inc. | -38.34 Million USD | -572.328% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1266.644% |
| Fortrea Holdings Inc. | -3.4 Million USD | -7483.265% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -103.587% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1380.851% |
| XBiotech Inc. | -24.55 Million USD | -949.929% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -299.955% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -311.345% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -161.954% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1103.3% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -367.144% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 57.498% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -277.747% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -452759.451% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -13.813% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1057.879% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -17.351% |
| NexImmune, Inc. | -32.34 Million USD | -697.143% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -4777.091% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1735.632% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 106.521% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -964.494% |
| Scopus BioPharma Inc. | -11.6 Million USD | -2120.8% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -120.749% |
| Ainos, Inc. | -13.77 Million USD | -1772.336% |
| Pluri Inc. | -20.88 Million USD | -1134.35% |
| Prothena Corporation plc | -147.02 Million USD | -75.362% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -126.424% |
| Celularity Inc. | -196.29 Million USD | -31.349% |
| Rallybio Corporation | -74.56 Million USD | -245.785% |
| Cue Biopharma, Inc. | -50.73 Million USD | -408.212% |
| MeiraGTx Holdings plc | -84.02 Million USD | -206.843% |
| Omeros Corporation | -117.81 Million USD | -118.848% |
| Humacyte, Inc. | -110.77 Million USD | -132.75% |
| Immunocore Holdings plc | -55.28 Million USD | -366.35% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1333.669% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1024.377% |
| Blueprint Medicines Corporation | -506.98 Million USD | 49.144% |
| CalciMedica, Inc. | -34.35 Million USD | -650.447% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -280.984% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -82.335% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -55.518% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 8.976% |
| Pulmatrix, Inc. | -14.12 Million USD | -1725.869% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -632.578% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -212.001% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 46.418% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -145.855% |
| Cytokinetics, Incorporated | -526.24 Million USD | 51.005% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -614.906% |
| Nutriband Inc. | -5.48 Million USD | -4600.387% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -537.88% |
| Vor Biopharma Inc. | -117.86 Million USD | -118.755% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 105.929% |
| Evogene Ltd. | -23.87 Million USD | -979.74% |
| ProKidney Corp. | -35.46 Million USD | -626.94% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -115.284% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -3186.401% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 59.914% |
| CorMedix Inc. | -46.33 Million USD | -456.399% |
| BioLineRx Ltd. | -60.61 Million USD | -325.365% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -153.412% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -527.845% |
| Atai Life Sciences N.V. | -40.22 Million USD | -540.988% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -219.691% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -241.403% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 11.759% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -824.921% |
| MediciNova, Inc. | -8.57 Million USD | -2907.998% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -109.148% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2977.905% |
| GeoVax Labs, Inc. | -25.96 Million USD | -892.927% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -7.772% |
| Biomea Fusion, Inc. | -117.25 Million USD | -119.889% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 58.853% |
| Mereo BioPharma Group plc | -29.46 Million USD | -775.012% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -68.339% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -23.152% |
| Absci Corporation | -110.56 Million USD | -133.192% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -755.161% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -155.691% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -9.28% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1930.666% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -33.617% |
| Allakos Inc. | -185.7 Million USD | -38.842% |
| Imunon, Inc. | -19.51 Million USD | -1221.196% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -164.89% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 342.916% |
| BioAtla, Inc. | -123.46 Million USD | -108.834% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2018.225% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1503.626% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 21.216% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -597.802% |
| XOMA Corporation | -40.83 Million USD | -531.459% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -153.098% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -117.555% |
| aTyr Pharma, Inc. | -50.38 Million USD | -411.681% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -194.062% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -69.895% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -8.454% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -634.164% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -3086.269% |
| Akari Therapeutics, Plc | -10 Million USD | -2476.249% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -382864.723% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 191.561% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3768.491% |
| UroGen Pharma Ltd. | -102.24 Million USD | -152.172% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -141.431% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -3215.223% |
| Orgenesis Inc. | -55.36 Million USD | -365.727% |
| Entera Bio Ltd. | -8.88 Million USD | -2800.562% |
| GH Research PLC | -35.58 Million USD | -624.509% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1137.193% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -233.167% |
| Xencor, Inc. | -126.08 Million USD | -104.487% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -6746.824% |
| Replimune Group, Inc. | -215.79 Million USD | -19.48% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1112.379% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 10376.246% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3768.491% |
| Portage Biotech Inc. | -75.33 Million USD | -242.228% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2977.905% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -166.754% |
| OncoCyte Corporation | -27.78 Million USD | -828.084% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1821.644% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2218.307% |
| Purple Biotech Ltd. | -19.88 Million USD | -1196.937% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3573.33% |
| scPharmaceuticals Inc. | -54.81 Million USD | -370.409% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1372.803% |
| HilleVax, Inc. | -123.56 Million USD | -108.659% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2451.014% |
| Tharimmune, Inc. | -9.31 Million USD | -2666.696% |
| Genprex, Inc. | -30.86 Million USD | -735.474% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -9.285% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -756.752% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -14368.631% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -4768.396% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1532286.039% |
| Savara Inc. | -54.69 Million USD | -371.372% |
| Curis, Inc. | -47.41 Million USD | -443.798% |
| Daré Bioscience, Inc. | -30.16 Million USD | -754.838% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1569.34% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -4529.754% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -764.769% |
| BeiGene, Ltd. | -881.7 Million USD | 70.758% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1110.815% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 40.914% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -226.554% |
| Erasca, Inc. | -125.04 Million USD | -106.196% |
| bluebird bio, Inc. | -211.91 Million USD | -21.668% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5056.107% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 253.796% |
| DBV Technologies S.A. | -72.72 Million USD | -254.524% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -5056.107% |
| Moderna, Inc. | -4.71 Billion USD | 94.531% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -542.057% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -4428.117% |
| Molecular Templates, Inc. | -8.12 Million USD | -3073.695% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -326.957% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -131.448% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -90.489% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -438.056% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -82.304% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -34.001% |
| MacroGenics, Inc. | -9.05 Million USD | -2746.445% |
| RenovoRx, Inc. | -10.23 Million USD | -2419.849% |
| Adicet Bio, Inc. | -142.65 Million USD | -80.734% |
| Prime Medicine, Inc. | -198.13 Million USD | -30.13% |
| Aditxt, Inc. | -32.38 Million USD | -696.246% |
| Adagene Inc. | -18.94 Million USD | -1260.846% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3426.269% |
| Quantum-Si incorporated | -95.96 Million USD | -168.686% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -116.612% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1668.659% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 294.839% |
| SciSparc Ltd. | -5.12 Million USD | -4933.795% |
| Vericel Corporation | -3.18 Million USD | -8002.797% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -214305.342% |
| Minerva Neurosciences, Inc. | -30 Million USD | -759.283% |
| Generation Bio Co. | -126.61 Million USD | -103.639% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -253.721% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -212.742% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 1.644% |
| Invivyd, Inc. | -198.64 Million USD | -29.796% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 24.605% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2868.156% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1230.54% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2511.211% |
| 2seventy bio, Inc. | -217.57 Million USD | -18.505% |
| ADMA Biologics, Inc. | -28.23 Million USD | -813.032% |
| Clene Inc. | -49.5 Million USD | -420.829% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1056.839% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -421.566% |
| GeoVax Labs, Inc. | -25.96 Million USD | -892.927% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 21.409% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -692.28% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1234.82% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -160.984% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -244.906% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -60.338% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 58.08% |
| Evaxion Biotech A/S | -22.12 Million USD | -1065.338% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -219.351% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -28.872% |
| Trevena, Inc. | -40.28 Million USD | -539.954% |
| Surrozen, Inc. | -43.04 Million USD | -499.022% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -272.944% |
| Cingulate Inc. | -23.53 Million USD | -995.524% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -3630.194% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -546.841% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -3243.82% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -185.812% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -320.701% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -333.308% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2056.674% |
| Kronos Bio, Inc. | -112.67 Million USD | -128.831% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -272.604% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -10165815.552% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -200.17% |
| Statera Biopharma, Inc. | -174.4 Million USD | -47.832% |
| ImmunityBio, Inc. | -583.19 Million USD | 55.79% |
| Korro Bio, Inc. | -81.17 Million USD | -217.635% |
| Kineta, Inc. | -14.09 Million USD | -1728.718% |
| BioVie Inc. | -32.12 Million USD | -702.698% |
| Codexis, Inc. | -76.24 Million USD | -238.183% |
| Celularity Inc. | -196.29 Million USD | -31.349% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -20.185% |
| Celcuity Inc. | -63.77 Million USD | -304.256% |
| Virax Biolabs Group Limited | -6.73 Million USD | -3729.057% |
| Cibus, Inc. | -267.62 Million USD | 3.66% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -539.367% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -619.977% |
| IN8bio, Inc. | -30 Million USD | -759.236% |
| Kodiak Sciences Inc. | -260.49 Million USD | 1.021% |
| Annexon, Inc. | -134.23 Million USD | -92.071% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -120.058% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -321.1% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -717.369% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 29.609% |
| Eyenovia, Inc. | -27.26 Million USD | -845.784% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1294.16% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -48092.71% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -237.457% |
| Arcellx, Inc. | -70.69 Million USD | -264.735% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -522.164% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -92.676% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -758.378% |
| Moolec Science SA | -51.78 Million USD | -397.85% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -392.316% |
| Geron Corporation | -184.12 Million USD | -40.029% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -514.264% |
| Royalty Pharma plc | 1.13 Billion USD | 122.72% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -89.643% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2799.648% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1113.709% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -50.19% |
| Humacyte, Inc. | -110.77 Million USD | -132.75% |
| Structure Therapeutics Inc. | -89.62 Million USD | -187.694% |
| 89bio, Inc. | -142.18 Million USD | -81.33% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -273.885% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2384.639% |
| Genelux Corporation | -28.29 Million USD | -811.16% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -787.084% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -45.569% |
| Notable Labs, Ltd. | -11.26 Million USD | -2188.983% |
| Liquidia Corporation | -78.5 Million USD | -228.439% |
| Mustang Bio, Inc. | -51.6 Million USD | -399.653% |
| Immunovant, Inc. | -259.33 Million USD | 0.58% |
| Quantum-Si incorporated | -95.96 Million USD | -168.686% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -253.925% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1230.329% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -168.602% |
| Acasti Pharma Inc. | -12.85 Million USD | -1905.999% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1048.066% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1515.315% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -41.36% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -5893.955% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1967.61% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -774.27% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -561.309% |
| PepGen Inc. | -78.62 Million USD | -227.921% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -766.106% |
| United Therapeutics Corporation | 984.8 Million USD | 126.181% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1058.27% |
| Solid Biosciences Inc. | -96.01 Million USD | -168.532% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5281.046% |
| Immuneering Corporation | -53.47 Million USD | -382.183% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4968.4% |
| Silo Pharma, Inc. | -3.7 Million USD | -6867.119% |
| Belite Bio, Inc | -31.63 Million USD | -715.095% |
| XOMA Corporation | -40.83 Million USD | -531.459% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -374.259% |
| Bionomics Limited | -15.49 Billion USD | 98.336% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -206.996% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -784.285% |
| uniQure N.V. | -308.47 Million USD | 16.418% |
| Cassava Sciences, Inc. | -97.21 Million USD | -165.212% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3426.269% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -108.888% |
| Forte Biosciences, Inc. | -31.47 Million USD | -719.135% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -3043.628% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -786.993% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -48092.71% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -882.887% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1464.034% |
| Altimmune, Inc. | -88.44 Million USD | -191.509% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -70.091% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -784.285% |
| Compugen Ltd. | -18.75 Million USD | -1274.805% |
| Peak Bio, Inc. | -1259.26 USD | -20474702.662% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -459.906% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1085.375% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 23.897% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -210.812% |
| Zura Bio Limited | -60.36 Million USD | -327.155% |
| PolyPid Ltd. | -23.86 Million USD | -980.373% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1538.895% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -210.812% |
| Instil Bio, Inc. | -156.08 Million USD | -65.184% |
| argenx SE | -295.05 Million USD | 12.615% |
| Immunome, Inc. | -106.8 Million USD | -141.401% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -506.747% |
| Verona Pharma plc | -54.36 Million USD | -374.224% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -158.045% |
| Shattuck Labs, Inc. | -87.29 Million USD | -195.346% |
| CervoMed Inc. | -2.17 Million USD | -11771.366% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -106.842% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1836.25% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -491.966% |
| Moolec Science SA | -51.78 Million USD | -397.85% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1490965.382% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -90.82% |
| AnaptysBio, Inc. | -163.61 Million USD | -57.58% |
| Design Therapeutics, Inc. | -66.86 Million USD | -285.617% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -216.691% |
| NeurAxis, Inc. | -14.62 Million USD | -1662.744% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -580.616% |
| Lumos Pharma, Inc. | -34.03 Million USD | -657.569% |
| Achilles Therapeutics plc | -69.66 Million USD | -270.101% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -158.045% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1193.351% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 8669.259% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -10165815.552% |
| Nutriband Inc. | -5.48 Million USD | -4600.387% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -156.046% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -430.44% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -234.45% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -658.996% |
| MoonLake Immunotherapeutics | -36 Million USD | -616.053% |
| Palisade Bio, Inc. | -12.3 Million USD | -1996.187% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -512.076% |
| Beam Therapeutics Inc. | -132.52 Million USD | -94.55% |
| Neurogene Inc. | -36.31 Million USD | -609.946% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -57.777% |
| AEON Biopharma, Inc. | -52.55 Million USD | -390.583% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -162.699% |
| Sesen Bio, Inc. | -19.88 Million USD | -1196.676% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -260.18% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1960.358% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 41.935% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -131.102% |
| Athira Pharma, Inc. | -117.67 Million USD | -119.11% |
| Vaccinex, Inc. | -20.25 Million USD | -1173.177% |
| HCW Biologics Inc. | -24.99 Million USD | -931.56% |
| XOMA Corporation | -40.83 Million USD | -531.459% |
| Nektar Therapeutics | -276.05 Million USD | 6.602% |
| Arvinas, Inc. | -367.3 Million USD | 29.804% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -382864.723% |
| Merus N.V. | -154.93 Million USD | -66.408% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -164.637% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -721.51% |
| Rezolute, Inc. | -68.45 Million USD | -276.621% |
| Clene Inc. | -49.5 Million USD | -420.829% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1571.679% |
| BeyondSpring Inc. | -21.02 Million USD | -1126.248% |
| Synlogic, Inc. | -57.28 Million USD | -350.108% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2066.465% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2281.591% |
| Peak Bio, Inc. | -1259.26 USD | -20474702.662% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -589.978% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2458.498% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -80.177% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 20.693% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -5482.008% |
| MannKind Corporation | -11.93 Million USD | -2059.75% |
| Ikena Oncology, Inc. | -68.16 Million USD | -278.24% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1126.89% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -177.438% |
| Gossamer Bio, Inc. | -179.81 Million USD | -43.385% |
| CohBar, Inc. | -11.96 Million USD | -2055.396% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -899.81% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -755.161% |
| Legend Biotech Corporation | -518.25 Million USD | 50.25% |
| Mural Oncology plc | -207.44 Million USD | -24.288% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -107.736% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1309.704% |
| Disc Medicine, Inc. | -76.42 Million USD | -237.347% |
| Champions Oncology, Inc. | -7.27 Million USD | -3443.582% |
| REGENXBIO Inc. | -263.49 Million USD | 2.149% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2329.372% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -442.745% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -578.797% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -157.411% |
| Vaxart, Inc. | -82.46 Million USD | -212.655% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 77349.725% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -586.771% |
| Cellectis S.A. | -101.05 Million USD | -155.129% |
| Longeveron Inc. | -21.41 Million USD | -1104.086% |
| Repare Therapeutics Inc. | -93.79 Million USD | -174.885% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 51.895% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -262.28% |
| Revolution Medicines, Inc. | -436.36 Million USD | 40.914% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -3823.771% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -736.462% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -271.873% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -298.305% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2527.979% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 107.123% |
| Denali Therapeutics Inc. | -145.22 Million USD | -77.54% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -214305.342% |
| Veru Inc. | -93.15 Million USD | -176.783% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -853.905% |
| Cingulate Inc. | -23.53 Million USD | -995.524% |
| Passage Bio, Inc. | -102.06 Million USD | -152.622% |
| Context Therapeutics Inc. | -23.96 Million USD | -975.9% |
| Exicure, Inc. | -16.91 Million USD | -1424.364% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -36.478% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -582.743% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -3862.166% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -39.611% |
| Nuvalent, Inc. | -126.21 Million USD | -104.273% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2351.877% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -196.77% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -744.13% |
| OmniAb, Inc. | -50.61 Million USD | -409.356% |
| Anew Medical, Inc. | 1.34 Million USD | 19253.57% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1506.924% |
| Lipocine Inc. | -16.35 Million USD | -1476.747% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -288.335% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -304.917% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -511.064% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -437.517% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1200.141% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 52.385% |
| Ocugen, Inc. | -63.07 Million USD | -308.749% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -169.326% |
| Q32 Bio Inc. | -112.96 Million USD | -128.248% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1399.715% |
| Alumis Inc. Common Stock | -154.99 Million USD | -66.35% |
| Equillium, Inc. | -13.33 Million USD | -1833.491% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -327.113% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -3127.795% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1267.715% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -336.395% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -125.127% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1302.936% |
| Dominari Holdings Inc. | -22.88 Million USD | -1026.785% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2978.794% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1173.24% |
| Bio-Techne Corporation | 168.1 Million USD | 253.375% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 26.771% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 300.097% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -111.628% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -579.594% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -128.894% |
| Nkarta, Inc. | -117.5 Million USD | -119.429% |
| BioCardia, Inc. | -11.57 Million USD | -2128.252% |
| Iterum Therapeutics plc | -38.37 Million USD | -571.942% |